stock & financial message boards
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 0

AMLN Amylin Pharmaceuticals, Stock Message Board

All Messages

AMLN Message Board Home | Join The AMLN Group | 

Page [1 of 1]
#9: AMLY Stock News : Eastbourne Calls on Amylin Employees to Help Shape the Company’s Future and Support Change to the Board
TheMachine
May 25, 2009 11:49:38 PM
Urges Them to Vote the WHITE Proxy Card and Elect All Three of Its Nominees Who Are Committed To Acting In Shareholders’ Best Interests Eastbourne Capital Management, L.L.C....
view message
ignore post
recommend post
#8: Amylin Pharmaceuticals Reports First Quarter Financial Results
TheMachine
April 23, 2008 12:56:12 AM
SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended March 31, 2008....
view message
ignore post
recommend post
#7: Amylin Pharmaceuticals to Present at Research & Development Day
FastFun
November 28, 2007 09:36:33 PM
  SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at its Research & Development (R&D) Day on Wednesday, November 28, 2007...
view message
ignore post
recommend post
#6: Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
FastFun
November 28, 2007 09:33:29 PM
  Findings validate novel integrated neurohormonal treatment of obesity (INTO) strategy SAN DIEGO, Nov. 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today...
view message
ignore post
recommend post
#5: Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
FastFun
November 28, 2007 09:32:48 PM
  - Both Groups Experienced Significant Weight Loss - - New Drug Application Filing Planned by the End of the First Half of 2009 - SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Oct. 31...
view message
ignore post
recommend post
#4: Amylin Pharmaceuticals to Webcast Third Quarter Results and Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
FastFun
October 17, 2007 09:27:43 AM
  Biotechnology industry alert provided by U.S. Equity News. Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on...
view message
ignore post
recommend post
#3: Amylin Pharmaceuticals to Webcast Third Quarter Results
FastFun
October 17, 2007 09:27:07 AM
  SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on Wednesday,...
view message
ignore post
recommend post
#2: Medarex to Present at the Natixis Bleichroeder's Hidden Gems Conference and Amylin Pharma OK's Symlin Pen-Injector Devices
FastFun
October 17, 2007 09:25:55 AM
  Biotechnology industry alert provided by U.S. Equity News. Medarex, Inc. (Nasdaq: MEDX) recently announced that it is scheduled to present at the Natixis Bleichroeder's Hidden Gems...
view message
ignore post
recommend post
#1: AMLN News Once Weekly Exenatide LAR Well Tolerated and Improved Glucose Control; Preliminary Results From Phase 2 Study Announced
Stock News Bot
August 22, 2005 09:30:00 AM
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 22, 2005--Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today...
view message
ignore post
recommend post
Page [1 of 1]

Group Home | Login if you want to post a message